.
ResMed Inc. (ASX:RMD, NYSE:RMD) has announced an annual profit boost of 12 per cent, underpinned by growth from its US markets.
The manufacturer and distributor of medical equipment generated a net profit of $254.9 million, an increase of more than $25 million from the previous financial year.
Resmed says American revenue lifted by 13 per cent in the fourth quarter while revenue from the rest of the business grew by 3 per cent over the year.
In the first half of the 2012 financial year ResMed reported a net profit of $112.6 million.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$40.79 |
Change
-0.460(1.12%) |
Mkt cap ! $23.89B | |||
| Open | High | Low | Value | Volume |
| $40.91 | $40.94 | $40.68 | $1.263M | 30.93K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 649 | $40.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $40.79 | 223 | 5 |
View Market Depth
| Last trade - 10.06am 15/09/2025 (20 minute delay) ? |
| RMD (ASX) Chart |